D-0134-2020 Class III Terminated

Recalled by Amneal Pharmaceuticals, Inc. — Brookhaven, NY

FDA drug recall D-0134-2020 was initiated by Amneal Pharmaceuticals, Inc. on Sep 24, 2019 and is designated Class III. Reason for recall: Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle The recall status is terminated (terminated Mar 4, 2021). Affected quantity: 9,720 100 count bottles.

Recall details

Product Type
Drugs
Report Date
Oct 16, 2019
Initiation Date
Sep 24, 2019
Termination Date
Mar 4, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,720 100 count bottles

Product description

Benazepril HCl Tablets, USP 40 mg, 100 count bottles, Rx only, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ NDC 65162-754-10

Reason for recall

Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle

Distribution pattern

Product was distributed to 13 major distributors throughout the United States who may have further distribute the product.

Code information

Lot # BB02619A, exp. date 04/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0134-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0134-2020. Report a data issue: hello@regdatalab.com.